BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 11511787)

  • 1. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Oncology; 2001; 60(3):242-51. PubMed ID: 11340376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression in hepatocellular carcinoma.
    Joo M; Kang YK; Kim MR; Lee HK; Jang JJ
    Liver; 2001 Apr; 21(2):89-95. PubMed ID: 11318977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T; Toyota N; Kaneko T; Kaibara N
    Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronobiologic contrast of expression of p53, p16, and cyclin D1 in hepatocarcinoma cells].
    Yu WX; Zhang YH; Cai Y; Zhou XJ
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):253-5. PubMed ID: 12223131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
    Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
    Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
    Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
    Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
    Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
    Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical demonstration of cyclins A, B, D1, D3 and E in hepatocellular carcinomas using tissue microarrays].
    Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):440-3. PubMed ID: 14633457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Jang JJ
    Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus.
    Hsia CC; Di Bisceglie AM; Kleiner DE; Farshid M; Tabor E
    J Med Virol; 1994 Sep; 44(1):67-73. PubMed ID: 7798888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.